Stock ZOM ZOMEDICA CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Zomedica Corp.

Equities

ZOM

CA98980M1095

Market Closed - Nyse
Other stock markets
 21:00:00 02/05/2024 BST 		5-day change 1st Jan Change
0.142 USD +0.28% Intraday chart for Zomedica Corp. +9.15% -29.07%
04-01 Zomedica Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
04-01 Zomedica Seeks Acquisitions CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Zomedica Corp. Reports Earnings Results for the Full Year Ended December 31, 2023
Zomedica Seeks Acquisitions
Zomedica Corp. Reiterates Revenue Guidance for Full Year 2024
Zomedica Corp. Announces Publication of Research Con Including TRUFORMA(R) Platform Is More Accurate Diagnostic Test for Feline Hyperthyroidism Than Chemiluminescent Immunoassay Platform
Zomedica Pharmaceuticals Reports Preliminary Q4 Revenue
Zomedica Corp. Provides Revenue Guidance for the Fourth Quarter and Full Year of 2023 and Full Year 2024
Zomedica Corp. Announces Expansion of Market Opportunity for TRUFORMA(R) Diagnostic Platform with Launch of Three New Assays for Commonly Performed Diagnostic Tests for Canine Gastrointestinal Disease
Zomedica Announces Presentation of Clinical Data in Support of New Indications for Pulsevet Shock Wave Therapy
Zomedica Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Zomedica Corp. acquired Qorvo Biotechnologies, LLC from Qorvo US, Inc. for $11.3 million.
Zomedica Corp. Launches its Newest Assay - Endogenous ACTH
Zomedica Pharmaceuticals Issued Warning From NYSE American For Failing to Meet Listing Requirement
Zomedica Completes Acquisition of Structured Monitoring Products
Zomedica Seeks M&A Opportunities
Zomedica Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Zomedica Corp. Launches Revolutionary TRUVIEW(TM) Digital Microscope with Advanced Optics, Automated Slide Preparation, and Telepathology Services
Zomedica Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023
Zomedica Seeks M&A Opportunities
Zomedica Pharmaceuticals CFO to Retire, Replacement Appointed
Zomedica Corp. Reports Earnings Results for the Full Year Ended December 31, 2022
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ZOM Stock
  4. News Zomedica Corp.
  5. Other languages